168 related articles for article (PubMed ID: 15449129)
21. Polyostotic fibrous dysplasia involving the thoracic spine with myelopathy: case report and review of the literature.
Wu FL; Liu ZJ; Liu XG; Yang SM; Jiang L; Wei F; Yu M
Spine J; 2014 Jan; 14(1):e11-5. PubMed ID: 24094990
[TBL] [Abstract][Full Text] [Related]
22. Maternal and infant outcome after pamidronate treatment of polyostotic fibrous dysplasia and osteogenesis imperfecta before conception: a report of four cases.
Chan B; Zacharin M
J Clin Endocrinol Metab; 2006 Jun; 91(6):2017-20. PubMed ID: 16551739
[TBL] [Abstract][Full Text] [Related]
23. [Fibrous dysplasia: differential diagnosis from Paget's disease].
Wagner P; Heilmann P; Schulz A; Nawroth P; Kasperk Ch
Dtsch Med Wochenschr; 2002 Oct; 127(43):2264-8. PubMed ID: 12397541
[TBL] [Abstract][Full Text] [Related]
24. Bisphosphonate-induced zebra lines in fibrous dysplasia of bone: histo-radiographic correlation in a case of McCune-Albright syndrome.
Corsi A; Ippolito E; Robey PG; Riminucci M; Boyde A
Skeletal Radiol; 2017 Oct; 46(10):1435-1439. PubMed ID: 28660402
[TBL] [Abstract][Full Text] [Related]
25. PET-positive polyostotic fibrous dysplasia mimicking Ollier disease.
Nishio J; Kuwabara Y; Nabeshima S; Iwasaki H; Naito M
In Vivo; 2013; 27(6):821-6. PubMed ID: 24292588
[TBL] [Abstract][Full Text] [Related]
26. An extensive hemimelic polyostotic fibrous dysplasia: a case report.
Mrabet D; Rekik S; Sahli H; Ben Amor M; Meddeb N; Sellami S
Rheumatol Int; 2012 Apr; 32(4):1075-8. PubMed ID: 21331571
[TBL] [Abstract][Full Text] [Related]
27. A randomized clinical trial comparing oral alendronate and intravenous pamidronate for the treatment of Paget's disease of bone.
Walsh JP; Ward LC; Stewart GO; Will RK; Criddle RA; Prince RL; Stuckey BG; Dhaliwal SS; Bhagat CI; Retallack RW; Kent GN; Drury PJ; Vasikaran S; Gutteridge DH
Bone; 2004 Apr; 34(4):747-54. PubMed ID: 15050907
[TBL] [Abstract][Full Text] [Related]
28. [Fibrous dysplasia of bone in a 12-year old girl].
Bieniasz J; Maj A; Noczyńska A
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(1):69-72. PubMed ID: 16704865
[TBL] [Abstract][Full Text] [Related]
29. Bone mineral density response to long-term bisphosphonate therapy in fibrous dysplasia.
Parisi MS; Oliveri MB; Mautalen CA
J Clin Densitom; 2001; 4(2):167-72. PubMed ID: 11477309
[TBL] [Abstract][Full Text] [Related]
30. Positive gallium-67 citrate uptake in a patient with polyostotic fibrous dysplasia.
Creagh MF; Nunan TO
Clin Nucl Med; 1988 Apr; 13(4):241-2. PubMed ID: 3163534
[TBL] [Abstract][Full Text] [Related]
31. [Polyostotic fibrous dysplasia. A clinical case report].
Gallesio C; Tagliabue M; Mazzeo R; De Gioanni PP
Minerva Stomatol; 1996 Nov; 45(11):533-40. PubMed ID: 9026699
[TBL] [Abstract][Full Text] [Related]
32. [Polyostotic fibrous dysplasia].
Sakuyama K; Ishikawa T; Fujikawa M; Mitsuda K
Rinsho Hoshasen; 1975 Dec; 20(13):1177-82. PubMed ID: 1240500
[No Abstract] [Full Text] [Related]
33. A customised replacement for polyostotic fibrous dysplasia of the upper femur. A 51-year follow-up.
Dunstan E; Tilley S; Briggs TW; Cannon SR
J Bone Joint Surg Br; 2005 Jan; 87(1):114-5. PubMed ID: 15686250
[TBL] [Abstract][Full Text] [Related]
34. An extensive type of polyostotic fibrous dysplasia.
Sener RN
Pediatr Radiol; 1997 Apr; 27(4):339-41. PubMed ID: 9094244
[TBL] [Abstract][Full Text] [Related]
35. Treatment of fibrous dysplasia of bone with intravenous pamidronate: long-term effectiveness and evaluation of predictors of response to treatment.
Chapurlat RD; Hugueny P; Delmas PD; Meunier PJ
Bone; 2004 Jul; 35(1):235-42. PubMed ID: 15207763
[TBL] [Abstract][Full Text] [Related]
36. Fibrous dysplasia of bone: case report with autopsy study 80 years after the original clinical recognition of the bone lesions.
Sissons HA; Malcolm AJ
Skeletal Radiol; 1997 Mar; 26(3):177-83. PubMed ID: 9108229
[TBL] [Abstract][Full Text] [Related]
37. [Fibrous dysplasia and osteofibrous dysplasia].
Exner GU; von Hochstetter AR
Orthopade; 1995 Feb; 24(1):50-6. PubMed ID: 7892008
[TBL] [Abstract][Full Text] [Related]
38. Two-year clinical trial of oral alendronate versus intravenous pamidronate in children with osteogenesis imperfecta.
DiMeglio LA; Peacock M
J Bone Miner Res; 2006 Jan; 21(1):132-40. PubMed ID: 16355282
[TBL] [Abstract][Full Text] [Related]
39. Octreotide effect on hypersecretion of growth hormone in a patient with fibrous dysplasia: a case report.
Chen HS; Hwu CM; Shih KC; Kwok CF; Ho LT
Zhonghua Yi Xue Za Zhi (Taipei); 1999 Aug; 62(8):554-9. PubMed ID: 10462834
[TBL] [Abstract][Full Text] [Related]
40. [Unilateral polyostotic fibrous dysplasia].
Steudel A; Birnbaum R
Rofo; 1985 May; 142(5):573-5. PubMed ID: 2988048
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
